TDO2 and neoplasm: Tryptophan metabolites generated by indoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO) have been shown to promote tumor growth and immune evasion in peritoneal cancers [74,75].